alexa Pharmacovigilance For Ayurveda, Siddha And Unani (ASU) Drugs: Current Status And Future Strategies
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials
October 27-29, 2014 Hyderabad International Convention Centre, India

Patil D A and Patil A G
Posters: J Pharmacovigilance
DOI: 10.4172/2329-6887.S1.014
Abstract
Medicinal plants based Traditional Systems of Medicine (TSM) are playing important role in providing healthcare to large section of population, especially in developing countries. Nowadays in developed countries interest is increasing in utilization of herbal products based on TSM. ASU drugs used in TSM pose threat if not prepared and administered properly. In the era of modern technology, scientific advancements, consumer awareness and the advent of evidence based medicine, there is inadequate genuine clinical trial evidence supporting the efficacy and safety of many ASU drugs. Further, a common misconception prevails among the people and practitioners that these drugs are without any side effects and safe to use. Selfmedication and misuse of over-the counter (OTC) medicines and traditional and complementary medicines are widespread, adding to the potential risk of Adverse Drug Reactions (ADRs) and drug-drug interactions. These and other factors are likely to increase the burden of drug-related morbidity and mortality in our country. It seems clear from the available evidence that ADRs have become a major global public health problem that needs to be addressed at all levels of health care. The lack of awareness and appreciation of the size and severity of the problem as well as the misclassification of ADRs as other diseases or the underlying condition are partially to blame for this silent epidemic. Pharmacovigilance is an important tool to analyse the drug particularly its side effects, if any. The present review discusses in brief the concept of Pharmacovigilance for ASU drugs.
Biography
Patil D A is Assistant Professor in Botany at Smt. C. H. M. College, Ulhasnagar, M.S., India. She holds a PhD degree from University of Mumbai, India. She has worked in the field of Botany, Biotechnology and Herbal Science at undergraduate and post-graduate levels since last 20 years. She is actively involved in research projects sanctioned by National Medicinal Plants Board, Dept. of AYUSH, Govt. of India, Ministry of Health and Family Welfare, New Delhi, India and University Grants Commission, New Delhi, India. She has more than 25 research publications to her credit in various Indian and International Journals. She is also listed on the editorial board of reputed journals.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords